Table 3

Distribution of injections by compound, administrator and by year

	Year
	2008		2009		2010		2011		2012		2013		Total
	n	%	n	%	n	%	n	%	n	%	n	%	n	%
Anti-VEGF
Bevacizumab	0	0	807	84	1367	100	1791	100	2671	99	4248	98	10 884	94
Ranibizumab	361	86	127	13	1	0.1	2	0.1	16	0.6	76	2	583	5
Pegaptanib sodium	59	14	30	3	0	0	0	0	0	0	0	0	89	0.8
Aflibercept	0	0	0	0	0	0	0	0	0	0	6	0.1	6	0.1
Total	420	100	964	100	1368	100	1793	100	2687	100	4330	100	11 562	100
Administrator
Physician	420	100	961	100	260	19	74	4.1	21	0.8	77	1.8	1813	16
Nurse	0	0	3	0.3	1108	81	1719	96	2665	99	4251	98	9746	84
NA	0		0		0		0		1		2		3
Total	420	100	964	100	1368	100	1793	100	2687	100	4330	100	11 562	100

NA, not available; VEGF, vascular endothelial growth factor.